649 related articles for article (PubMed ID: 19073853)
1. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
8. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of spasticity].
Autti-Rämö I
Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
[No Abstract] [Full Text] [Related]
11. [Botulinum toxin: a new dimension for spasticity].
Reichel G
MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
[TBL] [Abstract][Full Text] [Related]
12. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
13. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
16. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
17. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
[TBL] [Abstract][Full Text] [Related]
18. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886
[TBL] [Abstract][Full Text] [Related]
19. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
Moore AP; Ade-Hall RA; Smith CT; Rosenbloom L; Walsh HP; Mohamed K; Williamson PR
Neurology; 2008 Jul; 71(2):122-8. PubMed ID: 18606966
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
